The Role of Blood-Borne Microparticles in Inflammation and Hemostasis

Seminars in Thrombosis and Hemostasis

Volumn 41, Issue 6, 2015, Pages 590-606

  Suades, Rosa ^a   Padró, Teresa ^a   Badimon, Lina ^a,b  

^a Institut Català de Ciències Cardiovasculars   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

atherosclerosis; circulating microparticles; hemostasis; inflammation

Indexed keywords

ANGIOGENESIS; APOPTOSIS; ARTICLE; ATHEROSCLEROSIS; BLOOD VESSEL WALL; CARDIOVASCULAR DISEASE; CELL STRUCTURE; DISEASE ASSOCIATION; DISEASE COURSE; HEMOSTASIS; HUMAN; INFLAMMATION; MEMBRANE MICROPARTICLE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; THROMBOSIS; ADAPTIVE IMMUNITY; AUTOIMMUNE DISEASE; BLOOD; CELL AGING; COMPLICATION; DRUG EFFECTS; HEMATOLOGIC DISEASE; MOLECULARLY TARGETED THERAPY; PATHOLOGY; PHYSIOLOGY; THROMBOCYTE; THROMBOPHILIA; ULTRASTRUCTURE; VASCULAR ENDOTHELIUM;

AUTACOID; BIOLOGICAL MARKER;

ADAPTIVE IMMUNITY; APOPTOSIS; ATHEROSCLEROSIS; AUTOIMMUNE DISEASES; BIOMARKERS; BLOOD PLATELETS; CARDIOVASCULAR DISEASES; CELL AGING; CELL-DERIVED MICROPARTICLES; ENDOTHELIUM, VASCULAR; HEMATOLOGIC DISEASES; HEMOSTASIS; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; MOLECULAR TARGETED THERAPY; NEOVASCULARIZATION, PHYSIOLOGIC; THROMBOPHILIA;

EID: 84941801830     PISSN: 00946176     EISSN: 10989064     Source Type: Journal    
DOI: 10.1055/s-0035-1556591     Document Type: Article

References (215)

1. Jy W., Horstman L. L., Jimenez J. J., et al. Measuring circulating cell-derived microparticles. J Thromb Haemost: 2004; 2 10 1842 1851
2. Doeuvre L., Plawinski L., Toti F., Anglés-Cano E. Cell-derived microparticles: a new challenge in neuroscience. J Neurochem: 2009; 110 2 457 468
3. Robert S., Poncelet P., Lacroix R., et al. Standardization of platelet-derived microparticle counting using calibrated beads and a Cytomics FC500 routine flow cytometer: a first step towards multicenter studies? J Thromb Haemost: 2009; 7 1 190 197
4. Toth B., Nikolajek K., Rank A., et al. Gender-specific and menstrual cycle dependent differences in circulating microparticles. Platelets: 2007; 18 7 515 521
5. van der Zee P. M., Biró E., Ko Y., et al. P-selectin- and CD63-exposing platelet microparticles reflect platelet activation in peripheral arterial disease and myocardial infarction. Clin Chem: 2006; 52 4 657 664
6. Bretelle F., Sabatier F., Desprez D., et al. Circulating microparticles: a marker of procoagulant state in normal pregnancy and pregnancy complicated by preeclampsia or intrauterine growth restriction. Thromb Haemost: 2003; 89 3 486 492
7. Chaar V., Romana M., Tripette J., et al. Effect of strenuous physical exercise on circulating cell-derived microparticles. Clin Hemorheol Microcirc: 2011; 47 1 15 25
8. Tushuizen M. E., Nieuwland R., Scheffer P. G., Sturk A., Heine R. J., Diamant M. Two consecutive high-fat meals affect endothelial-dependent vasodilation, oxidative stress and cellular microparticles in healthy men. J Thromb Haemost: 2006; 4 5 1003 1010
9. Burnier L., Fontana P., Kwak B. R., Angelillo-Scherrer A. Cell-derived microparticles in haemostasis and vascular medicine. Thromb Haemost: 2009; 101 3 439 451
10. Berenson G. S., Srinivasan S. R., Bao W., Newman W. P. III, Tracy R. E., Wattigney W. A. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study. N Engl J Med: 1998; 338 23 1650 1656
11. Berckmans R. J., Nieuwland R., Böing A. N., Romijn F. P., Hack C. E., Sturk A. Cell-derived microparticles circulate in healthy humans and support low grade thrombin generation. Thromb Haemost: 2001; 85 4 639 646
12. Koga H., Sugiyama S., Kugiyama K., et al. Elevated levels of VE-cadherin-positive endothelial microparticles in patients with type 2 diabetes mellitus and coronary artery disease. J Am Coll Cardiol: 2005; 45 10 1622 1630
13. Preston R. A., Jy W., Jimenez J. J., et al. Effects of severe hypertension on endothelial and platelet microparticles. Hypertension: 2003; 41 2 211 217
14. Ueba T., Nomura S., Inami N., et al. Plasma level of platelet-derived microparticles is associated with coronary heart disease risk score in healthy men. J Atheroscler Thromb: 2010; 17 4 342 349
15. Bernal-Mizrachi L., Jy W., Fierro C., et al. Endothelial microparticles correlate with high-risk angiographic lesions in acute coronary syndromes. Int J Cardiol: 2004; 97 3 439 446
16. Bernal-Mizrachi L., Jy W., Jimenez J. J., et al. High levels of circulating endothelial microparticles in patients with acute coronary syndromes. Am Heart J: 2003; 145 6 962 970
17. Werner N., Wassmann S., Ahlers P., Kosiol S., Nickenig G. Circulating CD31+/annexin V+ apoptotic microparticles correlate with coronary endothelial function in patients with coronary artery disease. Arterioscler Thromb Vasc Biol: 2006; 26 1 112 116
18. Perez-Pujol S., Marker P. H., Key N. S. Platelet microparticles are heterogeneous and highly dependent on the activation mechanism: studies using a new digital flow cytometer. Cytometry A: 2007; 71 1 38 45
19. Morel O., Morel N., Hugel B., et al. The significance of circulating microparticles in physiology, inflammatory and thrombotic diseases [in French]. Rev Med Interne: 2005; 26 10 791 801
20. Heijnen H. F., Schiel A. E., Fijnheer R., Geuze H. J., Sixma J. J. Activated platelets release two types of membrane vesicles: microvesicles by surface shedding and exosomes derived from exocytosis of multivesicular bodies and alpha-granules. Blood: 1999; 94 11 3791 3799
21. Simak J., Gelderman M. P. Cell membrane microparticles in blood and blood products: potentially pathogenic agents and diagnostic markers. Transfus Med Rev: 2006; 20 1 1 26
22. Johnstone R. M. Exosomes biological significance: a concise review. Blood Cells Mol Dis: 2006; 36 2 315 321
23. Théry C., Ostrowski M., Segura E. Membrane vesicles as conveyors of immune responses. Nat Rev Immunol: 2009; 9 8 581 593
24. Jimenez J. J., Jy W., Mauro L. M., Soderland C., Horstman L. L., Ahn Y. S. Endothelial cells release phenotypically and quantitatively distinct microparticles in activation and apoptosis. Thromb Res: 2003; 109 4 175 180
25. Aatonen M., Grönholm M., Siljander P. R. Platelet-derived microvesicles: multitalented participants in intercellular communication. Semin Thromb Hemost: 2012; 38 1 102 113
26. Abrahams V. M., Straszewski S. L., Kamsteeg M., et al. Epithelial ovarian cancer cells secrete functional Fas ligand. Cancer Res: 2003; 63 17 5573 5581
27. Miyazaki Y., Nomura S., Miyake T., et al. High shear stress can initiate both platelet aggregation and shedding of procoagulant containing microparticles. Blood: 1996; 88 9 3456 3464
28. Schoenwaelder S. M., Yuan Y., Josefsson E. C., et al. Two distinct pathways regulate platelet phosphatidylserine exposure and procoagulant function. Blood: 2009; 114 3 663 666
29. Zwaal R. F., Comfurius P., Bevers E. M. Surface exposure of phosphatidylserine in pathological cells. Cell Mol Life Sci: 2005; 62 9 971 988
30. Cocucci E., Racchetti G., Meldolesi J. Shedding microvesicles: artefacts no more. Trends Cell Biol: 2009; 19 2 43 51
31. Flaumenhaft R. Formation and fate of platelet microparticles. Blood Cells Mol Dis: 2006; 36 2 182 187
32. Rand M. L., Wang H., Bang K. W., Packham M. A., Freedman J. Rapid clearance of procoagulant platelet-derived microparticles from the circulation of rabbits. J Thromb Haemost: 2006; 4 7 1621 1623
33. Rank A., Nieuwland R., Crispin A., et al. Clearance of platelet microparticles in vivo. Platelets: 2011; 22 2 111 116
34. Abdel-Monem H., Dasgupta S. K., Le A., Prakasam A., Thiagarajan P. Phagocytosis of platelet microvesicles and beta2- glycoprotein I. Thromb Haemost: 2010; 104 2 335 341
35. Schlegel R. A., Williamson P. Phosphatidylserine, a death knell. Cell Death Differ: 2001; 8 6 551 563
36. Wu Y., Tibrewal N., Birge R. B. Phosphatidylserine recognition by phagocytes: a view to a kill. Trends Cell Biol: 2006; 16 4 189 197
37. Distler J. H., Huber L. C., Hueber A. J., et al. The release of microparticles by apoptotic cells and their effects on macrophages. Apoptosis: 2005; 10 4 731 741
38. Ravichandran K. S., Lorenz U. Engulfment of apoptotic cells: signals for a good meal. Nat Rev Immunol: 2007; 7 12 964 974
39. Del Conde I., Shrimpton C. N., Thiagarajan P., López J. A. Tissue-factor-bearing microvesicles arise from lipid rafts and fuse with activated platelets to initiate coagulation. Blood: 2005; 106 5 1604 1611
40. Dasgupta S. K., Abdel-Monem H., Niravath P., et al. Lactadherin and clearance of platelet-derived microvesicles. Blood: 2009; 113 6 1332 1339
41. Fourcade O., Simon M. F., Viodé C., et al. Secretory phospholipase A2 generates the novel lipid mediator lysophosphatidic acid in membrane microvesicles shed from activated cells. Cell: 1995; 80 6 919 927
42. Dasgupta S. K., Le A., Chavakis T., Rumbaut R. E., Thiagarajan P. Developmental endothelial locus-1 (Del-1) mediates clearance of platelet microparticles by the endothelium. Circulation: 2012; 125 13 1664 1672
43. Valadi H., Ekström K., Bossios A., Sjöstrand M., Lee J. J., Lötvall J. O. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol: 2007; 9 6 654 659
44. Shai E., Rosa I., Parguiña A. F., Motahedeh S., Varon D., García Á. Comparative analysis of platelet-derived microparticles reveals differences in their amount and proteome depending on the platelet stimulus. J Proteomics: 2012; 76 Spec No 287 296
45. Dean W. L., Lee M. J., Cummins T. D., Schultz D. J., Powell D. W. Proteomic and functional characterisation of platelet microparticle size classes. Thromb Haemost: 2009; 102 4 711 718
46. Robertson C., Booth S. A., Beniac D. R., Coulthart M. B., Booth T. F., McNicol A. Cellular prion protein is released on exosomes from activated platelets. Blood: 2006; 107 10 3907 3911
47. Crawford N. The presence of contractile proteins in platelet microparticles isolated from human and animal platelet-free plasma. Br J Haematol: 1971; 21 1 53 69
48. Abid Hussein M. N., Meesters E. W., Osmanovic N., Romijn F. P., Nieuwland R., Sturk A. Antigenic characterization of endothelial cell-derived microparticles and their detection ex vivo. J Thromb Haemost: 2003; 1 11 2434 2443
49. Huang Y., Zhang J. L., Yu X. L., Xu T. S., Wang Z. B., Cheng X. C. Molecular functions of small regulatory noncoding RNA. Biochemistry (Mosc): 2013; 78 3 221 230
50. Mitchell P. S., Parkin R. K., Kroh E. M., et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A: 2008; 105 30 10513 10518
51. Pigati L., Yaddanapudi S. C., Iyengar R., et al. Selective release of microRNA species from normal and malignant mammary epithelial cells. PLoS ONE: 2010; 5 10 e13515
52. Weerheim A. M., Kolb A. M., Sturk A., Nieuwland R. Phospholipid composition of cell-derived microparticles determined by one-dimensional high-performance thin-layer chromatography. Anal Biochem: 2002; 302 2 191 198
53. Huber J., Vales A., Mitulovic G., et al. Oxidized membrane vesicles and blebs from apoptotic cells contain biologically active oxidized phospholipids that induce monocyte-endothelial interactions. Arterioscler Thromb Vasc Biol: 2002; 22 1 101 107
54. Sinauridze E. I., Kireev D. A., Popenko N. Y., et al. Platelet microparticle membranes have 50- to 100-fold higher specific procoagulant activity than activated platelets. Thromb Haemost: 2007; 97 3 425 434
55. Connor D. E., Exner T., Ma D. D., Joseph J. E. The majority of circulating platelet-derived microparticles fail to bind annexin V, lack phospholipid-dependent procoagulant activity and demonstrate greater expression of glycoprotein Ib. Thromb Haemost: 2010; 103 5 1044 1052
56. Yuana Y., Bertina R. M., Osanto S. Pre-analytical and analytical issues in the analysis of blood microparticles. Thromb Haemost: 2011; 105 3 396 408
57. Nieuwland R., Berckmans R. J., McGregor S., et al. Cellular origin and procoagulant properties of microparticles in meningococcal sepsis. Blood: 2000; 95 3 930 935
58. Keuren J. F., Magdeleyns E. J., Bennaghmouch A., Bevers E. M., Curvers J., Lindhout T. Microparticles adhere to collagen type I, fibrinogen, von Willebrand factor and surface immobilised platelets at physiological shear rates. Br J Haematol: 2007; 138 4 527 533
59. Mrvar-Brecko A., Sustar V., Jansa V., et al. Isolated microvesicles from peripheral blood and body fluids as observed by scanning electron microscope. Blood Cells Mol Dis: 2010; 44 4 307 312
60. Combes V., Simon A. C., Grau G. E., et al. In vitro generation of endothelial microparticles and possible prothrombotic activity in patients with lupus anticoagulant. J Clin Invest: 1999; 104 1 93 102
61. Rubin O., Crettaz D., Tissot J. D., Lion N. Pre-analytical and methodological challenges in red blood cell microparticle proteomics. Talanta: 2010; 82 1 1 8
62. van der Pol E., Coumans F., Varga Z., Krumrey M., Nieuwland R. Innovation in detection of microparticles and exosomes. J Thromb Haemost: 2013; 11 01 36 45
63. Donadee C., Raat N. J., Kanias T., et al. Nitric oxide scavenging by red blood cell microparticles and cell-free hemoglobin as a mechanism for the red cell storage lesion. Circulation: 2011; 124 4 465 476
64. Lozito T. P., Tuan R. S. Endothelial cell microparticles act as centers of matrix metalloproteinsase-2 (MMP-2) activation and vascular matrix remodeling. J Cell Physiol: 2012; 227 2 534 549
65. Terrisse A. D., Puech N., Allart S., et al. Internalization of microparticles by endothelial cells promotes platelet/endothelial cell interaction under flow. J Thromb Haemost: 2010; 8 12 2810 2819
66. Joly E., Hudrisier D. What is trogocytosis and what is its purpose? Nat Immunol: 2003; 4 9 815
67. Faille D., El-Assaad F., Mitchell A. J., et al. Endocytosis and intracellular processing of platelet microparticles by brain endothelial cells. J Cell Mol Med: 2012; 16 8 1731 1738
68. Rozmyslowicz T., Majka M., Kijowski J., et al. Platelet- and megakaryocyte-derived microparticles transfer CXCR4 receptor to CXCR4-null cells and make them susceptible to infection by X4-HIV. AIDS: 2003; 17 1 33 42
69. Escolar G., Lopez-Vilchez I., Diaz-Ricart M., White J. G., Galan A. M. Internalization of tissue factor by platelets. Thromb Res: 2008; 122 01 S37 S41
70. Morel O., Toti F., Jesel L., Freyssinet J. M. Mechanisms of microparticle generation: on the trail of the mitochondrion! Semin Thromb Hemost: 2010; 36 8 833 844
71. Morel O., Toti F., Hugel B., et al. Procoagulant microparticles: disrupting the vascular homeostasis equation? Arterioscler Thromb Vasc Biol: 2006; 26 12 2594 2604
72. Sims P. J., Faioni E. M., Wiedmer T., Shattil S. J. Complement proteins C5b-9 cause release of membrane vesicles from the platelet surface that are enriched in the membrane receptor for coagulation factor Va and express prothrombinase activity. J Biol Chem: 1988; 263 34 18205 18212
73. Tan K. T., Lip G. Y. The potential role of platelet microparticles in atherosclerosis. Thromb Haemost: 2005; 94 3 488 492
74. Key N. S. Analysis of tissue factor positive microparticles. Thromb Res: 2010; 125 01 S42 S45
75. Owens A. P. III, Mackman N. Microparticles in hemostasis and thrombosis. Circ Res: 2011; 108 10 1284 1297
76. Steppich B., Mattisek C., Sobczyk D., Kastrati A., Schömig A., Ott I. Tissue factor pathway inhibitor on circulating microparticles in acute myocardial infarction. Thromb Haemost: 2005; 93 1 35 39
77. Pérez-Casal M., Downey C., Cutillas-Moreno B., Zuzel M., Fukudome K., Toh C. H. Microparticle-associated endothelial protein C receptor and the induction of cytoprotective and anti-inflammatory effects. Haematologica: 2009; 94 3 387 394
78. Pérez-Casal M., Downey C., Fukudome K., Marx G., Toh C. H. Activated protein C induces the release of microparticle-associated endothelial protein C receptor. Blood: 2005; 105 4 1515 1522
79. Tans G., Rosing J., Thomassen M. C., Heeb M. J., Zwaal R. F., Griffin J. H. Comparison of anticoagulant and procoagulant activities of stimulated platelets and platelet-derived microparticles. Blood: 1991; 77 12 2641 2648
80. Satta N., Freyssinet J. M., Toti F. The significance of human monocyte thrombomodulin during membrane vesiculation and after stimulation by lipopolysaccharide. Br J Haematol: 1997; 96 3 534 542
81. Lacroix R., Dignat-George F. Microparticles: new protagonists in pericellular and intravascular proteolysis. Semin Thromb Hemost: 2013; 39 1 33 39
82. Mause S. F., von Hundelshausen P., Zernecke A., Koenen R. R., Weber C. Platelet microparticles: a transcellular delivery system for RANTES promoting monocyte recruitment on endothelium. Arterioscler Thromb Vasc Biol: 2005; 25 7 1512 1518
83. Brodsky S. V., Zhang F., Nasjletti A., Goligorsky M. S. Endothelium-derived microparticles impair endothelial function in vitro. Am J Physiol Heart Circ Physiol: 2004; 286 5 H1910 H1915
84. Densmore J. C., Signorino P. R., Ou J., et al. Endothelium-derived microparticles induce endothelial dysfunction and acute lung injury. Shock: 2006; 26 5 464 471
85. Agouni A., Lagrue-Lak-Hal A. H., Ducluzeau P. H., et al. Endothelial dysfunction caused by circulating microparticles from patients with metabolic syndrome. Am J Pathol: 2008; 173 4 1210 1219
86. Boulanger C. M., Scoazec A., Ebrahimian T., et al. Circulating microparticles from patients with myocardial infarction cause endothelial dysfunction. Circulation: 2001; 104 22 2649 2652
87. Huber L. C., Jüngel A., Distler J. H., et al. The role of membrane lipids in the induction of macrophage apoptosis by microparticles. Apoptosis: 2007; 12 2 363 374
88. Abid Hussein M. N., Böing A. N., Sturk A., Hau C. M., Nieuwland R. Inhibition of microparticle release triggers endothelial cell apoptosis and detachment. Thromb Haemost: 2007; 98 5 1096 1107
89. Abid Hussein M. N., Nieuwland R., Hau C. M., Evers L. M., Meesters E. W., Sturk A. Cell-derived microparticles contain caspase 3 in vitro and in vivo. J Thromb Haemost: 2005; 3 5 888 896
90. Böing A. N., Hau C. M., Sturk A., Nieuwland R. Platelet microparticles contain active caspase 3. Platelets: 2008; 19 2 96 103
91. Sarkar A., Mitra S., Mehta S., Raices R., Wewers M. D. Monocyte derived microvesicles deliver a cell death message via encapsulated caspase-1. PLoS ONE: 2009; 4 9 e7140
92. Huang P. H., Huang S. S., Chen Y. H., et al. Increased circulating CD31+/annexin V+ apoptotic microparticles and decreased circulating endothelial progenitor cell levels in hypertensive patients with microalbuminuria. J Hypertens: 2010; 28 8 1655 1665
93. Brill A., Dashevsky O., Rivo J., Gozal Y., Varon D. Platelet-derived microparticles induce angiogenesis and stimulate post-ischemic revascularization. Cardiovasc Res: 2005; 67 1 30 38
94. Kim H. K., Song K. S., Chung J. H., Lee K. R., Lee S. N. Platelet microparticles induce angiogenesis in vitro. Br J Haematol: 2004; 124 3 376 384
95. Mause S. F., Ritzel E., Liehn E. A., et al. Platelet microparticles enhance the vasoregenerative potential of angiogenic early outgrowth cells after vascular injury. Circulation: 2010; 122 5 495 506
96. Soleti R., Benameur T., Porro C., Panaro M. A., Andriantsitohaina R., Martínez M. C. Microparticles harboring Sonic Hedgehog promote angiogenesis through the upregulation of adhesion proteins and proangiogenic factors. Carcinogenesis: 2009; 30 4 580 588
97. Leroyer A. S., Rautou P. E., Silvestre J. S., et al. CD40 ligand+ microparticles from human atherosclerotic plaques stimulate endothelial proliferation and angiogenesis a potential mechanism for intraplaque neovascularization. J Am Coll Cardiol: 2008; 52 16 1302 1311
98. Arderiu G., Pena E., Badimon L. Angiogenic microvascular endothelial cells release microparticles rich in tissue factor that promotes postischemic collateral vessel formation. Arterioscler Thromb Vasc Biol: 2015; 35 2 348 357
99. Yang C., Mwaikambo B. R., Zhu T., et al. Lymphocytic microparticles inhibit angiogenesis by stimulating oxidative stress and negatively regulating VEGF-induced pathways. Am J Physiol Regul Integr Comp Physiol: 2008; 294 2 R467 R476
100. Ou Z. J., Chang F. J., Luo D., et al. Endothelium-derived microparticles inhibit angiogenesis in the heart and enhance the inhibitory effects of hypercholesterolemia on angiogenesis. Am J Physiol Endocrinol Metab: 2011; 300 4 E661 E668
101. Leroyer A. S., Isobe H., Lesèche G., et al. Cellular origins and thrombogenic activity of microparticles isolated from human atherosclerotic plaques. J Am Coll Cardiol: 2007; 49 7 772 777
102. Sambola A., Osende J., Hathcock J., et al. Role of risk factors in the modulation of tissue factor activity and blood thrombogenicity. Circulation: 2003; 107 7 973 977
103. Hugel B., Socié G., Vu T., et al. Elevated levels of circulating procoagulant microparticles in patients with paroxysmal nocturnal hemoglobinuria and aplastic anemia. Blood: 1999; 93 10 3451 3456
104. Lopez-Vilchez I., Escolar G., Diaz-Ricart M., Fuste B., Galan A. M., White J. G. Tissue factor-enriched vesicles are taken up by platelets and induce platelet aggregation in the presence of factor VIIa. Thromb Haemost: 2007; 97 2 202 211
105. Falati S., Liu Q., Gross P., et al. Accumulation of tissue factor into developing thrombi in vivo is dependent upon microparticle P-selectin glycoprotein ligand 1 and platelet P-selectin. J Exp Med: 2003; 197 11 1585 1598
106. Falati S., Gross P., Merrill-Skoloff G., Furie B. C., Furie B. Real-time in vivo imaging of platelets, tissue factor and fibrin during arterial thrombus formation in the mouse. Nat Med: 2002; 8 10 1175 1181
107. Gross P. L., Furie B. C., Merrill-Skoloff G., Chou J., Furie B. Leukocyte-versus microparticle-mediated tissue factor transfer during arteriolar thrombus development. J Leukoc Biol: 2005; 78 6 1318 1326
108. Zwicker J. I., Trenor C. C. III, Furie B. C., Furie B. Tissue factor-bearing microparticles and thrombus formation. Arterioscler Thromb Vasc Biol: 2011; 31 4 728 733
109. Fuster V., Badimon L., Cohen M., Ambrose J. A., Badimon J. J., Chesebro J. Insights into the pathogenesis of acute ischemic syndromes. Circulation: 1988; 77 6 1213 1220
110. Lopez-Vilchez I., Diaz-Ricart M., White J. G., Escolar G., Galan A. M. Serotonin enhances platelet procoagulant properties and their activation induced during platelet tissue factor uptake. Cardiovasc Res: 2009; 84 2 309 316
111. Merten M., Pakala R., Thiagarajan P., Benedict C. R. Platelet microparticles promote platelet interaction with subendothelial matrix in a glycoprotein IIb/IIIa-dependent mechanism. Circulation: 1999; 99 19 2577 2582
112. Siljander P., Carpen O., Lassila R. Platelet-derived microparticles associate with fibrin during thrombosis. Blood: 1996; 87 11 4651 4663
113. Raturi A., Miersch S., Hudson J. W., Mutus B. Platelet microparticle-associated protein disulfide isomerase promotes platelet aggregation and inactivates insulin. Biochim Biophys Acta: 2008; 1778 12 2790 2796
114. Suades R., Padró T., Vilahur G., Badimon L. Circulating and platelet-derived microparticles in human blood enhance thrombosis on atherosclerotic plaques. Thromb Haemost: 2012; 108 6 1208 1219
115. Rajavashisth T., Qiao J. H., Tripathi S., et al. Heterozygous osteopetrotic (op) mutation reduces atherosclerosis in LDL receptor- deficient mice. J Clin Invest: 1998; 101 12 2702 2710
116. Ferrante G., Nakano M., Prati F., et al. High levels of systemic myeloperoxidase are associated with coronary plaque erosion in patients with acute coronary syndromes: a clinicopathological study. Circulation: 2010; 122 24 2505 2513
117. Hoyer F. F., Giesen M. K., Nunes França C., Lütjohann D., Nickenig G., Werner N. Monocytic microparticles promote atherogenesis by modulating inflammatory cells in mice. J Cell Mol Med: 2012; 16 11 2777 2788
118. Wang J. G., Williams J. C., Davis B. K., et al. Monocytic microparticles activate endothelial cells in an IL-1β-dependent manner. Blood: 2011; 118 8 2366 2374
119. Sun J., Sukhova G. K., Wolters P. J., et al. Mast cells promote atherosclerosis by releasing proinflammatory cytokines. Nat Med: 2007; 13 6 719 724
120. Pitanga T. N., de Aragão França L., Rocha V. C., et al. Neutrophil-derived microparticles induce myeloperoxidase-mediated damage of vascular endothelial cells. BMC Cell Biol: 2014; 15 21
121. Zhou X., Nicoletti A., Elhage R., Hansson G. K. Transfer of CD4(+) T cells aggravates atherosclerosis in immunodeficient apolipoprotein E knockout mice. Circulation: 2000; 102 24 2919 2922
122. Martin S., Tesse A., Hugel B., et al. Shed membrane particles from T lymphocytes impair endothelial function and regulate endothelial protein expression. Circulation: 2004; 109 13 1653 1659
123. Mostefai H. A., Agouni A., Carusio N., et al. Phosphatidylinositol 3-kinase and xanthine oxidase regulate nitric oxide and reactive oxygen species productions by apoptotic lymphocyte microparticles in endothelial cells. J Immunol: 2008; 180 7 5028 5035
124. Scanu A., Molnarfi N., Brandt K. J., Gruaz L., Dayer J. M., Burger D. Stimulated T cells generate microparticles, which mimic cellular contact activation of human monocytes: differential regulation of pro- and anti-inflammatory cytokine production by high-density lipoproteins. J Leukoc Biol: 2008; 83 4 921 927
125. Caligiuri G., Nicoletti A., Poirier B., Hansson G. K. Protective immunity against atherosclerosis carried by B cells of hypercholesterolemic mice. J Clin Invest: 2002; 109 6 745 753
126. Diehl P., Aleker M., Helbing T., et al. Increased platelet, leukocyte and endothelial microparticles predict enhanced coagulation and vascular inflammation in pulmonary hypertension. J Thromb Thrombolysis: 2011; 31 2 173 179
127. Amabile N., Guérin A. P., Leroyer A., et al. Circulating endothelial microparticles are associated with vascular dysfunction in patients with end-stage renal failure. J Am Soc Nephrol: 2005; 16 11 3381 3388
128. Esposito K., Ciotola M., Giugliano D. Pioglitazone reduces endothelial microparticles in the metabolic syndrome. Arterioscler Thromb Vasc Biol: 2006; 26 8 1926
129. Jy W., Minagar A., Jimenez J. J., et al. Endothelial microparticles (EMP) bind and activate monocytes: elevated EMP-monocyte conjugates in multiple sclerosis. Front Biosci: 2004; 9 3137 3144
130. Burger D., Montezano A. C., Nishigaki N., He Y., Carter A., Touyz R. M. Endothelial microparticle formation by angiotensin II is mediated via Ang II receptor type I/NADPH oxidase/ Rho kinase pathways targeted to lipid rafts. Arterioscler Thromb Vasc Biol: 2011; 31 8 1898 1907
131. Altieri D. C. Regulation of leukocyte-endothelium interaction by fibrinogen. Thromb Haemost: 1999; 82 2 781 786
132. Mesri M., Altieri D. C. Endothelial cell activation by leukocyte microparticles. J Immunol: 1998; 161 8 4382 4387
133. Mesri M., Altieri D. C. Leukocyte microparticles stimulate endothelial cell cytokine release and tissue factor induction in a JNK1 signaling pathway. J Biol Chem: 1999; 274 33 23111 23118
134. Barry O. P., Pratico D., Lawson J. A., FitzGerald G. A. Transcellular activation of platelets and endothelial cells by bioactive lipids in platelet microparticles. J Clin Invest: 1997; 99 9 2118 2127
135. Tesse A., Martínez M. C., Hugel B., et al. Upregulation of proinflammatory proteins through NF-kappaB pathway by shed membrane microparticles results in vascular hyporeactivity. Arterioscler Thromb Vasc Biol: 2005; 25 12 2522 2527
136. Suades R., Padro T., Alonso R., et al. Circulating CD45+/CD3+ lymphocyte-derived microparticles map lipid-rich atherosclerotic plaques in familial hypercholesterolaemia patients. Thromb Haemost: 2014; 111 1 111 121
137. Ridker P. M., Danielson E., Fonseca F. A., et al. JUPITER Study Group. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med: 2008; 359 21 2195 2207
138. Chen K., Li W., Major J., Rahaman S. O., Febbraio M., Silverstein R. L. Vav guanine nucleotide exchange factors link hyperlipidemia and a prothrombotic state. Blood: 2011; 117 21 5744 5750
139. Boilard E., Nigrovic P. A., Larabee K., et al. Platelets amplify inflammation in arthritis via collagen-dependent microparticle production. Science: 2010; 327 5965 580 583
140. Barry O. P., Praticò D., Savani R. C., FitzGerald G. A. Modulation of monocyte-endothelial cell interactions by platelet microparticles. J Clin Invest: 1998; 102 1 136 144
141. Postea O., Vasina E. M., Cauwenberghs S., et al. Contribution of platelet CX(3)CR1 to platelet-monocyte complex formation and vascular recruitment during hyperlipidemia. Arterioscler Thromb Vasc Biol: 2012; 32 5 1186 1193
142. Montoro-García S., Shantsila E., Hernández-Romero D., et al. Small-size platelet microparticles trigger platelet and monocyte functionality and modulate thrombogenesis via P-selectin. Br J Haematol: 2014; 166 4 571 580
143. Vasina E. M., Cauwenberghs S., Feijge M. A., Heemskerk J. W., Weber C., Koenen R. R. Microparticles from apoptotic platelets promote resident macrophage differentiation. Cell Death Dis: 2011; 2 e211
144. Sadallah S., Amicarella F., Eken C., Iezzi G., Schifferli J. A. Ectosomes released by platelets induce differentiation of CD4+T cells into T regulatory cells. Thromb Haemost: 2014; 112 6 1219 1229
145. Weber A., Köppen H. O., Schrör K. Platelet-derived microparticles stimulate coronary artery smooth muscle cell mitogenesis by a PDGF-independent mechanism. Thromb Res: 2000; 98 5 461 466
146. Priou P., Gagnadoux F., Tesse A., et al. Endothelial dysfunction and circulating microparticles from patients with obstructive sleep apnea. Am J Pathol: 2010; 177 2 974 983
147. Meziani F., Tesse A., David E., et al. Shed membrane particles from preeclamptic women generate vascular wall inflammation and blunt vascular contractility. Am J Pathol: 2006; 169 4 1473 1483
148. Hansson G. K., Holm J., Jonasson L. Detection of activated T lymphocytes in the human atherosclerotic plaque. Am J Pathol: 1989; 135 1 169 175
149. Sarlon-Bartoli G., Bennis Y., Lacroix R., et al. Plasmatic level of leukocyte-derived microparticles is associated with unstable plaque in asymptomatic patients with high-grade carotid stenosis. J Am Coll Cardiol: 2013; 62 16 1436 1441
150. Rautou P. E., Leroyer A. S., Ramkhelawon B., et al. Microparticles from human atherosclerotic plaques promote endothelial ICAM-1-dependent monocyte adhesion and transendothelial migration. Circ Res: 2011; 108 3 335 343
151. Ardoin S. P., Shanahan J. C., Pisetsky D. S. The role of microparticles in inflammation and thrombosis. Scand J Immunol: 2007; 66 2-3 159 165
152. Mallat Z., Hugel B., Ohan J., Lesèche G., Freyssinet J. M., Tedgui A. Shed membrane microparticles with procoagulant potential in human atherosclerotic plaques: a role for apoptosis in plaque thrombogenicity. Circulation: 1999; 99 3 348 353
153. Radecke C. E., Warrick A. E., Singh G. D., Rogers J. H., Simon S. I., Armstrong E. J. Coronary artery endothelial cells and microparticles increase expression of VCAM-1 in myocardial infarction. Thromb Haemost: 2015; 113 3 605 616
154. Santos-Gallego C. G., Picatoste B., Badimón J. J. Pathophysiology of acute coronary syndrome. Curr Atheroscler Rep: 2014; 16 4 401
155. Forlow S. B., McEver R. P., Nollert M. U. Leukocyte-leukocyte interactions mediated by platelet microparticles under flow. Blood: 2000; 95 4 1317 1323
156. Pluskota E., Woody N. M., Szpak D., et al. Expression, activation, and function of integrin alphaMbeta2 (Mac-1) on neutrophil-derived microparticles. Blood: 2008; 112 6 2327 2335
157. Aras O., Shet A., Bach R. R., et al. Induction of microparticle- and cell-associated intravascular tissue factor in human endotoxemia. Blood: 2004; 103 12 4545 4553
158. Sadallah S., Eken C., Martin P. J., Schifferli J. A. Microparticles (ectosomes) shed by stored human platelets downregulate macrophages and modify the development of dendritic cells. J Immunol: 2011; 186 11 6543 6552
159. Nomura S., Omoto S., Yokoi T., et al. Effects of miglitol in platelet-derived microparticle, adiponectin, and selectin level in patients with type 2 diabetes mellitus. Int J Gen Med: 2011; 4 539 545
160. Nomura S., Shouzu A., Omoto S., et al. Effect of cilostazol on soluble adhesion molecules and platelet-derived microparticles in patients with diabetes. Thromb Haemost: 1998; 80 3 388 392
161. Mobarrez F., He S., Bröijersen A., et al. Atorvastatin reduces thrombin generation and expression of tissue factor, P-selectin and GPIIIa on platelet-derived microparticles in patients with peripheral arterial occlusive disease. Thromb Haemost: 2011; 106 2 344 352
162. Murakami T., Horigome H., Tanaka K., et al. Impact of weight reduction on production of platelet-derived microparticles and fibrinolytic parameters in obesity. Thromb Res: 2007; 119 1 45 53
163. Morel O., Hugel B., Jesel L., et al. Circulating procoagulant microparticles and soluble GPV in myocardial infarction treated by primary percutaneous transluminal coronary angioplasty. A possible role for GPIIb-IIIa antagonists. J Thromb Haemost: 2004; 2 7 1118 1126
164. Bulut D., Becker V., Mügge A. Acetylsalicylate reduces endothelial and platelet-derived microparticles in patients with coronary artery disease. Can J Physiol Pharmacol: 2011; 89 4 239 244
165. Judge H. M., Buckland R. J., Sugidachi A., Jakubowski J. A., Storey R. F. Relationship between degree of P2Y12 receptor blockade and inhibition of P2Y12-mediated platelet function. Thromb Haemost: 2010; 103 6 1210 1217
166. Shouzu A., Nomura S., Omoto S., Hayakawa T., Nishikawa M., Iwasaka T. Effect of ticlopidine on monocyte-derived microparticles and activated platelet markers in diabetes mellitus. Clin Appl Thromb Hemost: 2004; 10 2 167 173
167. Labiós M., Martínez M., Gabriel F., Guiral V., Munoz A., Aznar J. Effect of eprosartan on cytoplasmic free calcium mobilization, platelet activation, and microparticle formation in hypertension. Am J Hypertens: 2004; 17 9 757 763
168. Nomura S., Inami N., Kimura Y., et al. Effect of nifedipine on adiponectin in hypertensive patients with type 2 diabetes mellitus. J Hum Hypertens: 2007; 21 1 38 44
169. Morel O., Jesel L., Hugel B., et al. Protective effects of vitamin C on endothelium damage and platelet activation during myocardial infarction in patients with sustained generation of circulating microparticles. J Thromb Haemost: 2003; 1 1 171 177
170. Nébor D., Romana M., Santiago R., et al. Fetal hemoglobin and hydroxycarbamide moduate both plasma concentration and cellular origin of circulating microparticles in sickle cell anemia children. Haematologica: 2013; 98 6 862 867
171. Weitz I. C., Razavi P., Rochanda L., et al. Eculizumab therapy results in rapid and sustained decreases in markers of thrombin generation and inflammation in patients with PNH independent of its effects on hemolysis and microparticle formation. Thromb Res: 2012; 130 3 361 368
172. Diamant M., Tushuizen M. E., Abid-Hussein M. N., et al. Simvastatin-induced endothelial cell detachment and microparticle release are prenylation dependent. Thromb Haemost: 2008; 100 3 489 497
173. Mobarrez F., Egberg N., Antovic J., Bröijersen A., Jörneskog G., Wallén H. Release of endothelial microparticles in vivo during atorvastatin treatment; a randomized double-blind placebo-controlled study. Thromb Res: 2012; 129 1 95 97
174. Nomura S., Shouzu A., Omoto S., Nishikawa M., Iwasaka T. Effects of losartan and simvastatin on monocyte-derived microparticles in hypertensive patients with and without type 2 diabetes mellitus. Clin Appl Thromb Hemost: 2004; 10 2 133 141
175. Sommeijer D. W., Joop K., Leyte A., Reitsma P. H., ten Cate H. Pravastatin reduces fibrinogen receptor gpIIIa on platelet-derived microparticles in patients with type 2 diabetes. J Thromb Haemost: 2005; 3 6 1168 1171
176. Tramontano A. F., O'Leary J., Black A. D., Muniyappa R., Cutaia M. V., El-Sherif N. Statin decreases endothelial microparticle release from human coronary artery endothelial cells: implication for the Rho-kinase pathway. Biochem Biophys Res Commun: 2004; 320 1 34 38
177. Suades R., Padró T., Alonso R., Mata P., Badimon L. Lipid-lowering therapy with statins reduces microparticle shedding from endothelium, platelets and inflammatory cells. Thromb Haemost: 2013; 110 2 366 377
178. Lins L. C., França C. N., Fonseca F. A., et al. Effects of ezetimibe on endothelial progenitor cells and microparticles in high-risk patients. Cell Biochem Biophys: 2014; 70 1 687 696
179. Ferreira C. E., França C. N., Izar M. C., Camargo L. M., Roman R. M., Fonseca F. A. High-intensity statin monotherapy versus moderate-intensity statin plus ezetimibe therapy: effects on vascular biomarkers. Int J Cardiol: 2015; 180 78 79
180. van Dommelen S. M., Vader P., Lakhal S., et al. Microvesicles and exosomes: opportunities for cell-derived membrane vesicles in drug delivery. J Control Release: 2012; 161 2 635 644
181. Getts D. R., Terry R. L., Getts M. T., et al. Therapeutic inflammatory monocyte modulation using immune-modifying microparticles. Sci Transl Med: 2014; 6 219 219ra7
182. Koga H., Sugiyama S., Kugiyama K., et al. Elevated levels of remnant lipoproteins are associated with plasma platelet microparticles in patients with type-2 diabetes mellitus without obstructive coronary artery disease. Eur Heart J: 2006; 27 7 817 823
183. Goichot B., Grunebaum L., Desprez D., et al. Circulating procoagulant microparticles in obesity. Diabetes Metab: 2006; 32 1 82 85
184. Ferreira A. C., Peter A. A., Mendez A. J., et al. Postprandial hypertriglyceridemia increases circulating levels of endothelial cell microparticles. Circulation: 2004; 110 23 3599 3603
185. Heiss C., Amabile N., Lee A. C., et al. Brief secondhand smoke exposure depresses endothelial progenitor cells activity and endothelial function: sustained vascular injury and blunted nitric oxide production. J Am Coll Cardiol: 2008; 51 18 1760 1771
186. Chironi G., Simon A., Hugel B., et al. Circulating leukocyte-derived microparticles predict subclinical atherosclerosis burden in asymptomatic subjects. Arterioscler Thromb Vasc Biol: 2006; 26 12 2775 2780
187. Jayachandran M., Litwiller R. D., Owen W. G., et al. Characterization of blood borne microparticles as markers of premature coronary calcification in newly menopausal women. Am J Physiol Heart Circ Physiol: 2008; 295 3 H931 H938
188. Mallat Z., Benamer H., Hugel B., et al. Elevated levels of shed membrane microparticles with procoagulant potential in the peripheral circulating blood of patients with acute coronary syndromes. Circulation: 2000; 101 8 841 843
189. Nozaki T., Sugiyama S., Koga H., et al. Significance of a multiple biomarkers strategy including endothelial dysfunction to improve risk stratification for cardiovascular events in patients at high risk for coronary heart disease. J Am Coll Cardiol: 2009; 54 7 601 608
190. Diehl P., Nagy F., Sossong V., et al. Increased levels of circulating microparticles in patients with severe aortic valve stenosis. Thromb Haemost: 2008; 99 4 711 719
191. Bal L., Ederhy S., Di Angelantonio E., et al. Factors influencing the level of circulating procoagulant microparticles in acute pulmonary embolism. Arch Cardiovasc Dis: 2010; 103 6-7 394 403
192. Azzam H., Zagloul M. Elevated platelet microparticle levels in valvular atrial fibrillation. Hematology: 2009; 14 6 357 360
193. Rectenwald J. E., Myers D. D. Jr, Hawley A. E., et al. D-dimer, P-selectin, and microparticles: novel markers to predict deep venous thrombosis. A pilot study. Thromb Haemost: 2005; 94 6 1312 1317
194. Chirinos J. A., Heresi G. A., Velasquez H., et al. Elevation of endothelial microparticles, platelets, and leukocyte activation in patients with venous thromboembolism. J Am Coll Cardiol: 2005; 45 9 1467 1471
195. Lee Y. J., Jy W., Horstman L. L., et al. Elevated platelet microparticles in transient ischemic attacks, lacunar infarcts, and multiinfarct dementias. Thromb Res: 1993; 72 4 295 304
196. Simak J., Gelderman M. P., Yu H., Wright V., Baird A. E. Circulating endothelial microparticles in acute ischemic stroke: a link to severity, lesion volume and outcome. J Thromb Haemost: 2006; 4 6 1296 1302
197. Lackner P., Dietmann A., Beer R., et al. Cellular microparticles as a marker for cerebral vasospasm in spontaneous subarachnoid hemorrhage. Stroke: 2010; 41 10 2353 2357
198. Michelsen A. E., Noto A. T., Brodin E., Mathiesen E. B., Brosstad F., Hansen J. B. Elevated levels of platelet microparticles in carotid atherosclerosis and during the postprandial state. Thromb Res: 2009; 123 6 881 886
199. Jung K. H., Chu K., Lee S. T., et al. Circulating endothelial microparticles as a marker of cerebrovascular disease. Ann Neurol: 2009; 66 2 191 199
200. Tantawy A. A., Matter R. M., Hamed A. A., Shams El Din El Telbany M. A. Platelet microparticles in immune thrombocytopenic purpura in pediatrics. Pediatr Hematol Oncol: 2010; 27 4 283 296
201. Galli M., Grassi A., Barbui T. Platelet-derived microvesicles in thrombotic thrombocytopenic purpura and hemolytic uremic syndrome. Thromb Haemost: 1996; 75 3 427 431
202. Jimenez J. J., Jy W., Mauro L. M., Horstman L. L., Soderland C., Ahn Y. S. Endothelial microparticles released in thrombotic thrombocytopenic purpura express von Willebrand factor and markers of endothelial activation. Br J Haematol: 2003; 123 5 896 902
203. Simak J., Holada K., Risitano A. M., Zivny J. H., Young N. S., Vostal J. G. Elevated circulating endothelial membrane microparticles in paroxysmal nocturnal haemoglobinuria. Br J Haematol: 2004; 125 6 804 813
204. Warkentin T. E., Hayward C. P., Boshkov L. K., et al. Sera from patients with heparin-induced thrombocytopenia generate platelet-derived microparticles with procoagulant activity: an explanation for the thrombotic complications of heparin-induced thrombocytopenia. Blood: 1994; 84 11 3691 3699
205. Hughes M., Hayward C. P., Warkentin T. E., Horsewood P., Chorneyko K. A., Kelton J. G. Morphological analysis of microparticle generation in heparin-induced thrombocytopenia. Blood: 2000; 96 1 188 194
206. Sellam J., Proulle V., Jüngel A., et al. Increased levels of circulating microparticles in primary Sjögren's syndrome, systemic lupus erythematosus and rheumatoid arthritis and relation with disease activity. Arthritis Res Ther: 2009; 11 5 R156
207. Jy W., Tiede M., Bidot C. J., et al. Platelet activation rather than endothelial injury identifies risk of thrombosis in subjects positive for antiphospholipid antibodies. Thromb Res: 2007; 121 3 319 325
208. Dignat-George F., Camoin-Jau L., Sabatier F., et al. Endothelial microparticles: a potential contribution to the thrombotic complications of the antiphospholipid syndrome. Thromb Haemost: 2004; 91 4 667 673
209. Guiducci S., Distler J. H., Jüngel A., et al. The relationship between plasma microparticles and disease manifestations in patients with systemic sclerosis. Arthritis Rheum: 2008; 58 9 2845 2853
210. Erdbruegger U., Grossheim M., Hertel B., et al. Diagnostic role of endothelial microparticles in vasculitis. Rheumatology (Oxford): 2008; 47 12 1820 1825
211. Sabatier F., Darmon P., Hugel B., et al. Type 1 and type 2 diabetic patients display different patterns of cellular microparticles. Diabetes: 2002; 51 9 2840 2845
212. Minagar A., Jy W., Jimenez J. J., et al. Elevated plasma endothelial microparticles in multiple sclerosis. Neurology: 2001; 56 10 1319 1324
213. Chamouard P., Desprez D., Hugel B., et al. Circulating cell-derived microparticles in Crohn's disease. Dig Dis Sci: 2005; 50 3 574 580
214. Faure V., Dou L., Sabatier F., et al. Elevation of circulating endothelial microparticles in patients with chronic renal failure. J Thromb Haemost: 2006; 4 3 566 573
215. Lok C. A., Van Der Post J. A., Sargent I. L., et al. Changes in microparticle numbers and cellular origin during pregnancy and preeclampsia. Hypertens Pregnancy: 2008; 27 4 344 360